GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Cowin Biotech Co Ltd (SHSE:688426) » Definitions » Construction In Progress

Jiangsu Cowin Biotech Co (SHSE:688426) Construction In Progress : ¥1.1 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Jiangsu Cowin Biotech Co Construction In Progress?

Jiangsu Cowin Biotech Co's quarterly construction in progress declined from Mar. 2024 (¥0.4 Mil) to Jun. 2024 (¥0.0 Mil) but then increased from Jun. 2024 (¥0.0 Mil) to Sep. 2024 (¥1.1 Mil).

Jiangsu Cowin Biotech Co's annual construction in progress increased from Dec. 2021 (¥64.8 Mil) to Dec. 2022 (¥110.9 Mil) but then declined from Dec. 2022 (¥110.9 Mil) to Dec. 2023 (¥0.0 Mil).


Jiangsu Cowin Biotech Co Construction In Progress Historical Data

The historical data trend for Jiangsu Cowin Biotech Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Cowin Biotech Co Construction In Progress Chart

Jiangsu Cowin Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial - 0.61 64.81 110.90 -

Jiangsu Cowin Biotech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 - 0.42 - 1.09

Jiangsu Cowin Biotech Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Jiangsu Cowin Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Yaocheng Avenue, 4th Floor, TQB Building, Jiangsu Province, Taizhou, CHN, 225300
Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.
Executives
Yin Jian Feng Director
Zhuang Zhi Hua Directors, senior managers

Jiangsu Cowin Biotech Co Headlines

No Headlines